Compare COUR & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COUR | CDNA |
|---|---|---|
| Founded | 2012 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 932.9M | 1.1B |
| IPO Year | 2021 | 2007 |
| Metric | COUR | CDNA |
|---|---|---|
| Price | $5.24 | $20.03 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 6 |
| Target Price | $10.53 | ★ $28.00 |
| AVG Volume (30 Days) | ★ 6.1M | 733.8K |
| Earning Date | 04-23-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 39.22 | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | ★ $757,500,000.00 | $48,324,000.00 |
| Revenue This Year | $9.43 | $16.01 |
| Revenue Next Year | $6.40 | $11.31 |
| P/E Ratio | ★ N/A | $409.60 |
| Revenue Growth | 9.04 | ★ 18.93 |
| 52 Week Low | $5.00 | $10.96 |
| 52 Week High | $13.56 | $23.24 |
| Indicator | COUR | CDNA |
|---|---|---|
| Relative Strength Index (RSI) | 40.74 | 47.72 |
| Support Level | $5.11 | $16.63 |
| Resistance Level | $6.41 | $21.20 |
| Average True Range (ATR) | 0.33 | 1.33 |
| MACD | -0.10 | -0.22 |
| Stochastic Oscillator | 11.81 | 38.34 |
Coursera Inc is an online learning platform that connects learners, educators, and institutions with the goal of providing educational content that is affordable, accessible, and relevant. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The company operates through two reporting segments: Consumer and Enterprise. The majority of revenue is generated from the Consumer segment. The consumer segment targets individual learners seeking to obtain hands-on learning, gain valuable job skills, receive professional-level certifications, and otherwise increase their knowledge to start or advance their careers.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.